Fund Research for GMO US Growth III (GMGWX)

  • Fund Overview

    Fund Inception Date: Dec 30, 1988
    Category: Large Growth
    Overall Risk: Below Average
    Fund Family: GMO
    Return Since Inception: 9.02%
    YTD Return: 23.37%
    Yield (TTM): 1.54%
    Net Assets: 39.3 M
    Morningstar Rating:
    3 of 5

    The investment seeks long-term capital growth. The fund typically makes equity investments in U.S. companies that issue stocks included in the Russell 1000 index. Under normal circumstances, it invests at least 80% of assets in investments tied economically to the U.S. It is nondiversified.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player
    Size
    Average Market Cap $40,288 M
    Market Capitalization Portfolio
    Giant 58.62%
    Large 19.56%
    Medium 20.20%
    Small 1.62%
    Micro 0.00%
    Morningstar Rating as of 10/31/2009
    YTD Returns as of 11/25/2009    		 Style Box Detail calculations do not include the fund's short positions (if any)

  • Fund Performance

    10 year Growth Chart
    Growth of $10,000 from 12/31/1998 to 10/31/2009
    Mouseover the chart to see values for each month.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player

    Total Annualized Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Fund 23.37% 29.71% -3.30% -0.24% -2.23% 9.02%
    +/- Category -9.83% -12.12% 0.38% -1.62% -0.77% —
    +/- S&P 500 TR -1.77% -3.44% 2.20% -0.99% -0.95% —

    Standardized Annual Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Month (as of 10/31/2009) 15.07% 10.71% -5.18% -0.66% -2.23% 9.02%
    Quarter (as of 09/30/2009) 15.62% -3.87% -4.17% -0.47% -1.79% 9.09%
    Fund and Category YTD, 1yr, 3yr and 5yr Returns as of 11/25/2009
    Index YTD,1yr, 3ys and 5yr Returns as of 11/25/2009 10 yr and Since Inception Returns as of 10/31/2009
    Inception Date: 12/30/1988
    Ratings are based on risk-adjusted performance.
    View Total Returns

  • Fund Portfolio Profile

    Sector Breakdown

    Stocks
    Information 26.55%
    Service 42.16%
    Manufacturing 27.71%

    Asset Allocation

    Short Long Net Assets
    Cash — 3.57% 3.57%
    Stocks — 96.43% 96.43%
    Bonds — 0.00% 0.00%
    Other — 0.00% 0.00%
    Foreign Stocks
    (as a % of assets)    		 — 0.00% 0.00%
    Data as of 08/31/2009 Data as of 08/31/2009 View Fund Portfolio

    Top 10 Holdings

    Sector P/E Return as of 10/31/2009 Net Assets
    - MICROSOFT CORP (MSFT) Software 19.34 43.62% 4.48%
    + INTERNATIONAL BUSINESS MACHS (IBM) Hardware 13.12 45.87% 3.97%
    - WAL MART STORES INC (WMT) Consumer Services 15.88 -9.53% 3.58%
    + State Str Instl Invt Tr Treas Mmkt Fd In — — — 3.05%
    + ABBOTT LABS (ABT) Healthcare 15.16 -2.59% 2.78%
    + JOHNSON & JOHNSON (JNJ) Healthcare 13.82 0.90% 2.67%
    + PROCTER & GAMBLE CO (PG) Consumer Goods 17.51 -2.46% 2.61%
    - CISCO SYS INC (CSCO) Hardware 24.22 40.55% 2.51%
    - ORACLE CORP (ORCL) Software 20.55 18.67% 2.46%
    + COCA COLA CO (KO) Consumer Goods 21.52 20.06% 2.43%
    + Increase - Decrease = No change * New since last portfolio
    Top 10 holdings account for the fund's short positions (if any). Net short positions appear shaded.
    P/E as of 11/25/2009
    All other data as of 05/31/2009
    View Fund Portfolio

  • Sales Information

    Sales Charge %

    Initial —
    Deferred —
    Taken from prospectus dated 09/24/2009
    Expense Ratio (based on net assets) 0.46%
    Taken from annual report dated 02/28/2009

  • Fund Management

    Thomas Hancock
    Start Date: 03/23/2009
    Hancock is co-head of the GMO quantitative equity team and lead manager for international quantitative portfolios. Prior to joining GMO in 1995, he was a research scientist at Siemens and a software engineer at IBM.
    Sam Wilderman
    Start Date: 04/30/2005
    Wilderman is co-head of the GMO quantitative equity team and lead manager for U.S. quantitative portfolios. Previously at GMO, he was responsible for research and portfolio management for the GMO Emerging Markets Strategies.